A new study published in The Lancet Infectious Diseases journal has found that the risk of delayed acute complications after non-hospitalized SARS-CoV-2 infection is low, but persistent symptoms in this...

Schools and stores reopened in several parts of Europe on Monday as the continent eased out of months of COVID-19 lockdowns, but India remained in the grip of a devastating outbreak. Rapid vaccination...

Early in the COVID-19 pandemic, healthcare systems scrambled to modify patient care processes—particularly when it came to strategies aimed at reducing the risk of hospital-related complications. A...

New York Governor Andrew Cuomo announced a major easing of coronavirus restrictions Monday, including the imminent resumption of 24-hour operations on the city subway. The announcement highlights how...

At the start of the COVID-19 pandemic, very little was known about SARS-CoV-2, the virus that causes COVID-19. Over the past year, more evidence has become available on how the virus is transmitted, who...

The unprecedented development of COVID-19 vaccines less than a year after discovery of this virus was enabled by more than $17 billion of research on vaccine technologies funded by the NIH prior to the...

ZURICH (Reuters) – Germany’s CureVac filed in Switzerland for a rolling review of its COVID-19 vaccine candidate, the Swiss drugs regulator Swissmedic said on Monday, as yet another maker of...

CDC to meet to discuss J&J vaccine safety Harvard Global Health Institute director Dr. Ashish Jha provides insight on ‘Fox News Live.’ Experts at the European Medicines Agency are preparing...

CDC to meet to discuss J&J vaccine safety Harvard Global Health Institute director Dr. Ashish Jha provides insight on ‘Fox News Live.’ The Georgia Aquarium announced on Sunday that its Asian...

The global death toll from the coronavirus topped a staggering 3 million people Saturday amid repeated setbacks in the worldwide vaccination campaign and a deepening crisis in places such as Brazil, India...